Pride and Prejudice by Jane Austen The Reading Guide Reading Group Questions 1. Would you have enjoyed Pride and Prejudice as much if Jane were its heroine? 2. Does Mr Darcy’s character change throughout the novel, or does Elizabeth’s – and the reader’s – perception of him change? Or both? Discuss how Jane Austen handles both 3. Jane Austen wrote i
Rlf-dwcc website (2)Robert L. Findling, M.D., M.B.A. Rocco L. Motto, M.D. Chair of Child and Adolescent Psychiatry Professor of Psychiatry & Pediatrics Director, Child & Adolescent Psychiatry University Hospitals Case Medical Center
International MBA: London School of Economics, London, UK; New York University,
New York, NY; HEC, Paris, France
Medical school: Medical College of Virginia, Richmond, VA
Undergraduate: Johns Hopkins University, Baltimore, MD
Improvement of clinical outcomes for children and adolescents with psychiatric
disorders; treatment research in children and adolescents with psychiatric conditions;
psychopharmacology studies in adults with ADHD; developing evidence-based
assessment methodologies and diagnostic criteria for bipolar disorder in children;
pharmacokinetics and the biodisposition of psychotropic medications in pediatric patients
Selected honors and awards:
2011 American Academy of Child & Adolescent Psychiatry, Distinguished
2007-present American College of Neuropsychopharmacology, Member
1. Findling RL, Youngstrom EA, McNamara NK, Stansbrey RJ, Wynbrandt JL,
Adegbite C, Rowles BM, Demeter CA, Frazier TW, Calabrese JR. A double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder. Journal of Clinical Psychiatry 2012;73(1):57-63. 2. Stocks JD, Taneja BK, Baroldi P, Findling RL. A phase 2a randomized, parallel
group, dose-ranging study of molindone in children with attention-deficit/hyperactivity disorder and persistent, serious conduct problems. Journal of Child and Adolescent Psychopharmacology 2012;22(2):102-111. 3. Van Meter AR, Youngstrom EA, Findling RL. Cyclothymic disorder: a critical
review. Clinical Psychology Review 2012;32(4):229-243. 4. Van Meter AR, Youngstrom EA, Youngstrom JK, Feeny NC, Findling RL.
Examining the validity of cyclothymic disorder in a youth sample. Journal of Affective Disorders 2011;132(1-2):55-63. 5. Findling RL, Childress AC, Cutler AJ, Gasior M, Hamdani M, Ferreira-Cornwell
MC, Squires L. Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2011;50(4):395-405. 6. Marcus RN, Owen R, Manos G, Mankoski R, Kamen L, McQuade RD, Carson WH, Findling RL. Safety and tolerability of aripiprazole for irritability in pediatric patients
with autistic disorder: a 52-week, open-label, multicenter study. Journal of Clinical
7. Findling RL, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, Frazier JA,
Sikich L, Kowatch R, Lingler J, Faber J, Rowles BM, Clemons TE, Taylor-Zapata P. Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. Journal of Child and Adolescent Psychopharmacology 2011;21(3):195-205. 8. Findling RL, Horwitz SM, Birmaher B, Kowatch RA, Fristad MA, Youngstrom EA,
Frazier TW, Fristad MA, Axelson D, Ryan N, Demeter CA, Depew J, Fields B, Gill MK, Deyling EA, Birmaher B, Rowles BM and Arnold LE. Clinical characteristics of children receiving antipsychotic medication. Journal of Child and Adolescent Psychopharmacology 2011;21(4):311-319. 9. Frazier TW, Youngstrom EA, Horwitz SM, Demeter CA, Fristad MA, Arnold LE, Birmaher B, Kowatch RA, Axelson D, Gill MK, Findling RL. Relationship of
persistent manic symptoms to the diagnosis of pediatric bipolar disorder. Journal of
Clinical Psychiatry 2011;72(6):846-853.
10. Findling RL, Youngstrom EA, Fristad MA, Birmaher B, Kowatch RA, Arnold LE,
Frazier TW, Axelson D, Ryan N, Demeter CA, Gill MK, Fields B, Depew J, Kennedy SM, Marsh L, Rowles BM, Horwitz SM. Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study. Journal of Clinical Psychiatry 2010;71(12):1664-1672. 11. Horwitz SM, Demeter CA, Pagano ME, Youngstrom EA, Fristad MA, Arnold LE, Birmaher B, Gill MK, Axelson D, Kowatch RA, Frazier TW, Findling RL.
Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design,
and initial screening results. Journal of Clinical Psychiatry 2010;71(11):1511-151.
12. Findling RL, Johnson JL, McClellan J, Frazier JA, Vitiello B, Hamer RM,
Lieberman JA, Ritz L, McNamara NK, Lingler J, Hlastala S, Pierson L, Puglia M, Maloney AE, Kaufman EM, Noyes N, Sikich L. Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum Study (TEOSS). Journal of the American Academy of Child and Adolescent Psychiatry 2010;49(6):583-594. 13. Findling RL, Landersdorfer CB, Kafantaris V, Pavuluri M, McNamara NK,
McClellan J, Frazier JA, Sikich L, Kowatch R, Lingler J, Faber J, Taylor-Zapata P, Jusko WJ. First-dose pharmacokinetics of lithium carbonate in children and adolescents. Journal of Clinical Psychopharmacology 2010;30(4):404-410. 14. Findling RL, Frazier JA, Kafantaris V, Kowatch R, McClellan J, Pavuluri M, Sikich
L, Hlastala S, Hooper SR, Demeter CA, Bedoya D, Brownstein B, Taylor-Zapata P. The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation. Child and Adolescent Psychiatry and Mental Health 2008;2(1):21.
Publication List M David Osselton 1974 - Present 1. Osselton, M.D., Baum, H. and Beechey, R.B. Isolation, Purification and Characterisation of Aurovertin B Biochemical Society Transactions (1974) 2 pp200-202. 2. Beechey, R.B., Osselton, M.D., Baum, H., Linnett, P.E and Mitchell, A.D. Citreoviridin Diacetate: A New Inhibitor of the Mitochondrial ATP Synthetase. Membrane Prote